title: Podoplanin and CD34 in peripheral nerve sheath tumours: focus on neurofibromatosis 1-associated atypical neurofibroma.
abstract: Patients suffering from neurofibromatosis type 1 and 2 (NF1 and NF2) are the main risk groups to develop peripheral nerve sheath tumours (PNSTs). In the present study, adhesion molecules CD34 and podoplanin were assessed in regard to their value for tumour classification and as indicators for tumour progression. A total of 103 NF1-, NF2- and schwannomatosis-associated neurofibromas, schwannomas and malignant peripheral nerve sheath tumours (MPNST), as well as 20 sporadic vestibular schwannomas and 9 control tissue samples, were labelled immunohistochemically for detection of podoplanin and CD34. CD34 was shown to be expressed in MPNST and all benign PNSTs except for the compact cellular parts of both, schwannomas and atypical neurofibromas. Podoplanin showed an inverse expression pattern to CD34 labelling mainly the compact parts of schwannoma and atypical neurofibroma. MPNSTs were characterized by strong podoplanin staining at the invasive front. NF1-patients who suffered from atypical neurofibromas did not develop MPNST at a higher frequency than other NF1-patients, although these tumours expressed podoplanin. Ki-67 proliferation indices did not differ significantly between neurofibromas, atypical neurofibromas and schwannomas. In accordance with other studies, CD34 was found to be of limited value for classification and grading of PNST due to its ubiquitous expression. Podoplanin expression in schwannoma and atypical neurofibroma adds to other phenotypic and genotypic similarities between these tumours, like nuclear atypia, regressive changes and euploid polyploidisation. Podoplanin expression in atypical neurofibroma was not associated with tumour progression towards MPNST.
authors.affiliation: Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
authors.forename: Urs
authors.initials: U
authors.lastname: Naber
authors.forename: Reinhard E
authors.initials: RE
authors.lastname: Friedrich
authors.forename: Markus
authors.initials: M
authors.lastname: Glatzel
authors.forename: Victor Felix
authors.initials: VF
authors.lastname: Mautner
authors.forename: Christian
authors.initials: C
authors.lastname: Hagel
mesh_terms: D000328:Adult; D018952:Antigens, CD34 / Q000096:biosynthesis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D018450:Disease Progression; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008562:Membrane Glycoproteins / Q000096:biosynthesis*; D018317:Nerve Sheath Neoplasms / Q000378:metabolism / Q000473:pathology; D009442:Neurilemmoma / Q000378:metabolism / Q000473:pathology; D009456:Neurofibromatosis 1 / Q000378:metabolism* / Q000473:pathology*; D000098853:Podoplanin
chemical_list: D018952:Antigens, CD34; D014408:Biomarkers, Tumor; D008562:Membrane Glycoproteins; C117468:PDPN protein, human; D000098853:Podoplanin
references.citation: Cancer. 2007 Apr 1;109(7):1406-12
references.pmid: 17330850
references.citation: Blood. 2007 Aug 1;110(3):1076-7
references.pmid: 17644746
references.citation: Blood. 1990 Jun 15;75(12):2417-26
references.pmid: 1693532
references.citation: J Neurooncol. 2007 Apr;82(2):187-92
references.pmid: 17111191
references.citation: Immunity. 2005 Jan;22(1):43-57
references.pmid: 15664158
references.citation: Cell Stem Cell. 2007 Oct 11;1(4):443-57
references.pmid: 18371380
references.citation: Cell. 1990 Aug 10;62(3):599-608
references.pmid: 2116237
references.citation: Am J Clin Pathol. 2000 Jul;114(1):123-6
references.pmid: 10884807
references.citation: Anticancer Res. 2008 Sep-Oct;28(5B):2997-3006
references.pmid: 19031946
references.citation: Cell Oncol. 2004;26(5-6):335-45
references.pmid: 15623944
references.citation: Br J Dermatol. 2008 May;158(5):1008-12
references.pmid: 18363759
references.citation: J Cutan Pathol. 2009 Jan;36(1):89-102
references.pmid: 19125742
references.citation: Am J Surg Pathol. 1993 Oct;17(10):1039-45
references.pmid: 7690524
references.citation: Blood. 1990 May 15;75(10):1941-6
references.pmid: 1692488
references.citation: Int J Cancer. 2005 Mar 1;113(6):899-910
references.pmid: 15515019
references.citation: JAMA. 1997 Jul 2;278(1):51-7
references.pmid: 9207339
references.citation: J Exp Med. 1989 May 1;169(5):1721-31
references.pmid: 2469766
references.citation: Mod Pathol. 2005 Jan;18(1):105-10
references.pmid: 15389250
references.citation: J Cell Sci. 2008 Nov 15;121(Pt 22):3683-92
references.pmid: 18987355
references.citation: Anticancer Res. 2007 Jul-Aug;27(4A):1819-22
references.pmid: 17649778
references.citation: Neurology. 2005 Jun 14;64(11):1838-45
references.pmid: 15955931
references.citation: Cell. 1993 Mar 12;72(5):791-800
references.pmid: 8453669
references.citation: Clin Genet. 2008 Oct;74(4):358-66
references.pmid: 18647326
references.citation: Br J Cancer. 2007 Jan 15;96(1):1-5
references.pmid: 17179989
references.citation: Am J Clin Pathol. 2008 Jun;129(6):886-93
references.pmid: 18480004
references.citation: Virchows Arch. 2006 Aug;449(2):200-6
references.pmid: 16736189
references.citation: Br J Dermatol. 2005 Jul;153(1):79-82
references.pmid: 16029330
references.citation: Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):428-32
references.pmid: 16404595
references.citation: Blood. 1995 Jan 1;85(1):96-105
references.pmid: 7528578
references.citation: J Clin Invest. 1988 Mar;81(3):951-5
references.pmid: 2893812
references.citation: J Med Genet. 2002 May;39(5):311-4
references.pmid: 12011145
references.citation: Blood. 1996 Jan 1;87(1):1-13
references.pmid: 8547630
references.citation: Mol Cell Biol. 2009 Mar;29(6):1472-86
references.pmid: 19103750
references.citation: Cancer Cell. 2006 Apr;9(4):261-72
references.pmid: 16616332
references.citation: Curr Opin Neurol. 2003 Feb;16(1):27-33
references.pmid: 12544854
references.citation: Childs Nerv Syst. 1999 Jul;15(6-7):295-308
references.pmid: 10461778
references.citation: Adv Anat Pathol. 2009 Jan;16(1):62-4
references.pmid: 19098468
references.citation: Arch Neurol. 1988 May;45(5):575-8
references.pmid: 3128965